Our performance, productivity,
quality, positive attitude and customer appreciation are the major forte
that has contributed in our success. Being a responsible corporate
citizen, we try to minimise the risk of pollution and take all possible
measures to protect & safeguard the environment.
Our Products
We offer the following Active Pharmaceutical Ingredients (Bulk Drugs)
and Drug intermediates.
- Cetrizine Di Hydrochloride EP/BP/IP,
- Pantoprazole Sodium
- Levocetrizine Di Hydrochoride IP
- Nimesulide BP/EP
- Couple amine hydrochloride
- 4-chloro benzhydryl piperzine
We also offer the following products of our associate companies
which is as under:
| Active
Pharmaceutical Ingredients (API's ) |
| Therapeutic Category |
Name of the API |
Pharmacopoeia |
| ACE inhibitors |
Perindopril erbumine |
EP |
| Trandolapril |
EP |
| Lipid Lowering agent |
Atorvastatin Calcium (Amorphous) |
In-house |
| Atorvastatin Calcium (Crystalline) |
In-house |
| Calcium channel blockers |
Amlodepine Besylate |
EP |
| Anti-platelet agents |
Clopidogrel bisulphate (Form I) |
USP |
| Clopidogrel bisulphate (Form II) |
USP |
| Oncology |
Docetaxel Anhydrous |
In-house |
| Gemcitabine hydrochloride |
EP/USP |
| Capecitabine |
In-house |
| Methotrexate * |
EP/USP |
| Mercaptopurine * |
EP/USP |
| Paclitaxel hydrochloride * |
EP/USP |
| Irinotecan HCL * |
In-house |
| Topotecan Hcl * |
In-house |
| Gefitanib * |
In-house |
| Imatinib Mesylate * |
In-house |
| Anti-retrovirals |
Efavirenz |
USP (Draft) |
| Lamivudine |
USP |
| Nevirapine * |
USP |
| Ritonavir * |
USP |
| Stavudine |
USP |
| Zidovudine |
USP |
| Anti-asthmatics |
Budesonide |
BP |
| Ciclesonide |
In-house |
| Fluticasone propionate |
BP |
| Mometasone furoate |
USP |
| Montelukast Sodium |
In-house |
| NSAID's |
Naproxen |
USP |
| Bromfenac * |
USP |
| Anti-depressants |
Citalopram hydrobromide |
In-house |
| Escitalopram oxalate |
In-house |
| Milnacipran * |
In-house |
| Duloxetine hydrochloride * |
In-house |
| Anti-histamines |
Levocetirizine dihydrochloride |
In-house/IP |
| Cetirizine dihydrochloride |
EP/BP |
| Fexofenadine hydrochloride # |
In-house /USP |
| Decongestants |
Ephedrine Hcl |
BP/EP/USP |
| Ephedrine Sulfate # |
USP |
| Pseudoephedrine Hcl |
BP/EP/USP |
| Pseudoephedrine Sulfate # |
USP |
| L-Phenylephrine * |
EP/USP |
| Expectorant |
Bromhexine Hydrochloride |
BP/EP |
| Anti-Convulsant |
Pregabalin * |
In-house |
| Proton Pump Inhibitors |
Pantoprazole sodium |
In-house |
| Rabeprazole sodium * |
In-house |
| Anti-malaria |
Artesunate Sodium |
Ph.Int |
| Artemether |
Ph.Int |
| Alpha Beta Artemether & Arteether |
Ph.Int |
| Lumefantrine |
Ph.Int |
| Sedative-hypnotic |
Zopiclone |
|
| Anti emetic |
Metoclopramide hydrochloride |
BP/EP/USP |
| Antifungal |
Fluconazole # |
EP/USP |
| Intermediates
and Side Chains |
| Intermediate |
CAS No. |
API/End use |
CIMC Chloride
3-(2-Chlorophenyl)-5-Methyl Isoxazole-4-Carbonyl Chloride |
25629-50-9 |
Cloxacillin |
DCIMC Chloride
3-(2,6 Dichlorophenyl)-5-Methyl Isoxazole-4-Carbonyl Chloride |
4462-55-9 |
Dicloxacillin |
FCIMC Chloride
3-(2-Chloro-6-fluorophenyl)-5-Methyl Isoxazole-4-Carbonyl Chloride
|
69399-79-6 |
Flucloxacillin |
PMIC Chloride
3-Phenyl-5-Methyl Isoxazole-4-Carbonyl Chloride |
16883-16-2 |
Oxacillin |
EDPCC
4-ethyl-2,3-dioxo-pierazine-carbonyl chloride |
59703-00-3 |
Piperacillin |
EPCP
a-(4-Ethyl-2,3-dioxo-1-piperazine- carbonyl-amino)- phenyl acetic
acid |
|
|
| 63422-71-9 |
FEX MCDPA
Azacyclonol Base |
1798-50-1 |
Fexofenadine |
LX IV
5-deoxy-1,2,3-tri-O-acetylribose |
62211-93-2 |
Capacitabine |
GMC - XL2
2-deoxy-2,2-difluoro-D-erythropentafuranose-1-ulose-3,5-dibenzoate |
122111-01-7 |
Gemcitabine HCl |
| LM3 |
147126-73-6 |
Lamivudine |
| (1-3-oxathiolane-2-carboxylic
acid-5-(4-amino-2-oxo-1-(2H)-pyrimidinyl-5-methyl-2-(1-methyl
ethyl)-cyclohexyl ester |
| 2-Chloro-4-N-(2-chloro-4-methyl-3-pyridyl)-3-pyridine
carboxamide |
133627-46-0 |
Nevirapine |
| 2-Chloro-4-methyl-pyridine-3-amine |
133627-45-7 |
|
| 1-4(-Azido-5-trityloximethyl-tetrahydro-furan-2-yl)-5-methyl-1h-pyrimidine-2,4-dione |
|
Zidovudine |
DKT-3
4-Fluoro-a-(2-methyl-1-oxopropyl)-?-oxo-N,ß-diphenyl benzene
butanamide (DKT3) |
125971-96-2 |
Atorvastatin Calcium |
ATS-5
( R )-4-cyano-3-hydroxybutyrica acid ethyl ester |
|
| 141942-85-0 |
ATS-8
(4R,cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
(ATS-8) |
|
| 125971-94-0 |
ATV-1
(4R-cis)
-1,1-dimethylethyl-6-[2[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-phenylamino)
carbonyl]-1H-pyrrol-1-ylethyl]-2,2-dimethyl-1,3-dioxane-4-Acetate |
|
| 125971-95-1 |
| Ethyl 4-Chloro Acetoacetate |
638-07-3 |
Amlodipine |
| Phthaloyl Amlodipine |
88150-62-3 |
| 4,5,6,7-Tetrahydrothieno[3,2-c] Pyridine |
54903-50-3 |
Clopidogrel |
| 2-Thiophene Ethylamine |
30433-91-1 |
| S (-)
-3-(dimethylamino)-1-(thiophen-2-yl)propane -1 -ol |
|
Duloxetine |
| S (+) - N, N - dimethyl - 3- (naphthalen
-1-yloxy)-3-(thiophen-2-yl) propan -1 - amine |
132335-47-8 |
| DIOL |
142569-70-8 |
Montelukast |
| S] -1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl
]phenyl]]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl-1-ol]] |
| AST |
142569-69-5 |
|
| (S) - 2-
{3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]-phenyl]3-hydroxypropyl}benzoic
acid methyl ester |
|
|
| N-[ (S) -1- Carbethoxybutyl -(S) - Alanine |
82834-12-6 |
Perindopril |
| (2S,3aS,7aS) octahydro indole -2-carboxylic
acid |
80875-98-5 |
Ramipril |
| RX5 |
93779-29-4 |
| Octa hydro cyclopenta(b) pyrrole-2-benzyl
Carboxylate hydrochloride (Racemate) |
|
|
| RX7 |
|
| Octa hydro cyclopenta(b) pyrrole-2-benzyl
Carboxylate hydrochloride (resolved) |
93779-31-8 |
| Octahydroindol-2-carboxylic acid
(rac.7aR/3aS/2R, 7aS/3aR/2S |
145438-94-4 |
Trandolapril |
| N[(s)-(+)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanine |
82717-96-2 |
| N-[4-cyano-3-(trifluoromethyl)Phenyl]-2-methyloxirane-2-carboxamide |
90357-51-0 |
Bicalutamide |
| N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)thio]-2-hydroxy
-2-methylpropanamide |
90356-78-8 |
| 11-Piperazin-1-yl-dibenzo[b.f] [1,4] thiazepine
dihydrochloride |
111974-74-74 |
Quetiapine |
| 6-Chloro-5-(2-chloroacetyl)-2-oxyindole |
118289-55-7 |
Ziprasidone |
| 6-Chloro-5-(2-chloroethyl)-2-oxyindole |
118307-04-3 |
| 3-Chloro-1,2-Benzisothiazole |
2634-33-5 |
| Mica Acid |
80554-17-8 |
Cefixime |
| Mica Ester |
80554-17-8 |
| Chloro Acid |
111230-59-2 |
Cephalosporins |
| Bromo Acid |
65782-39-1 |
| Ortho Chloro Benzoic Acid |
118-91-2 |
Dyes, Electroplating & Food
industry |
| Benzaldehyde -2-Sulphonic Acid ( Sodium Salt) |
1008-72-6 |
| 2-Mercapto Benzimidazole |
583-39-1 |
Tyre Industry |
| Mono Methyl Aceto Acetamide |
20306-75-6 |
Agro Chemical |
| Aceto Acetanilide |
102-01-2 |
Pigment Intermediates |
| Aceto Acet ortho Toluidide |
93-68-5 |
| Aceto Acet para Toluidide |
2415-85-2 |
| Aceto Acet ortho Anisidide |
95-12-9 |
| Aceto Acet para Anisidide |
5349-98-9 |
| Aceto Acet orhtochloro Anilide |
93-70-9 |
| Aceto Acet para chloro Anilide |
101-92-8 |
| Phosphorous Tri Chloride (PCl3) |
|
Fine Chemcials |
| Phosphorous Oxy Chloride (POCl3) |
|
| Phosphorous Penta Chloride (PCl5) |
|
Our
Core Management Team
Our management team comprises of all professionals and experienced
persons like:
- Mr. Ghanshyam Kurmi - Managing Director of the Company
He is enriched with more than 14 years of experience in
pharmaceutical industry. He had opportunity to work with leading
Multi-national companies in the field.
- Mr. N. Satyanarayana - Director
He is a practicing Chartered Accountant with a total experience of
more than a decade and a half in the areas of Finance, Taxations,
Accounting etc.
- Dr. Vilas R. Lokhande
He has experience of 23 years with dedicated 7 years in research
Department of Chemotherapy, Mumbai. His Professional career stints
include Food Drugs and Chemicals Limited, Ventron Chemicals Limited
and Union Fibro Chemicals Ltd.
Infrastructure
Our production unit is strategically located at Gaddapotaram Industrial
Area of Andhra Pradesh. This location offers various advantages such as
access to quality personnel, abundant requisite resources and common
effluent treatment facilities.
We use eco-friendly machineries such as advanced effluent treatment
facility with high TDS evaporation setup. The other important asset of
our infrastructure is highly experienced and dedicated workforce.
Quality
We aim to achieve and sustain excellence in all our activities starting
from the concept of the product to its finalization. Our products are
made as per Inter-national quality standards and no compromise is done
with the same. Our products are strictly monitored at each stage of
production under the guidance of quality control experts. All the
products are checked and tested in our fully equipped labs prior to the
dispatch.
Logistic Support
We have a wide distribution network and our associations with reliable
C&F agents ensure us timely delivery of our products to our clients
in any corner of the world. We are committed to provide best customer
service and timely delivery of the product to the desired destination.
Why
Us
Some of the factors that have made us favorite amongst our worldwide
customers are as follows:
- International quality products
- Competitive Pricing
- Timely deliveries
- Customer focused approach
Contact Us or Send
Online
Business Enquiry
Mr. K Ravi Kumar
Apex Drugs & Intermediates Limited
210, Ram Enclave Erragadda
Hyderabad - 500 018, Andhra Pradesh,
(India)
Phone : +(91)-(40)- 23706034 / 65596034
Mobile No : +(91)- 9963182223
Fax : +(91)-(40)- 23707368
E-mail : ravi@apexdrugs.net,
marketing@apexdrugs.net
